Definition
What is Litigation and Enforcement?
Regulatory and civil litigation risks, including class actions, liability claims, and government enforcement proceedings related to chemical safety, environmental impact, and product compliance.
Regulatory and civil litigation risks, including class actions, liability claims, and government enforcement proceedings related to chemical safety, environmental impact, and product compliance.
Foresight tracks Litigation and Enforcement developments and surfaces the alerts most likely to matter before they turn into missed deadlines, recalls, or escalation work.
Not ready for a trial? Take the 3-minute readiness assessment
Current activity
In line with the prior 8-week baseline
3-month trend
Latest alerts below
Last updated
24 May 2026, 21:34
Source-backed regulatory and guidance signals tracked by Foresight, with the newest developments first.
Delaware SB 297 Advances to House Judiciary, Clarifying Consumer Fraud Act Scope
Delaware’s SB 297, which clarifies that the state Consumer Fraud Act covers unfair or deceptive conduct before, during, and after consumer transactions, has passed the Senate and advanced to the House Judiciary Committee in May 2026. If enacted, this would significantly broaden enforcement exposure for businesses in Delaware by extending consumer-fraud risk beyond advertising and point-of-sale interactions to ongoing customer communications, collections, and after-sales performance.
US DOJ Lodges Proposed CERCLA Consent Decree for Burley Demolition Asbestos Site (Idaho)
In May 2026, the US Department of Justice lodged a proposed CERCLA consent decree requiring a private party to reimburse EPA USD 10,000 in past response costs for the Burley Demolition Asbestos Site in Idaho. This enforcement action highlights ongoing Superfund cost-recovery at asbestos demolition sites and opens a 30-day public comment window, underscoring potential liabilities for owners or operators of similarly contaminated properties.
Texas Commission On Environmental Quality Agreed And Enforcement Orders; Opportunity To Comment (Comments Due 23 June 2026)
Texas environmental regulator TCEQ has published a Texas Register notice listing 40 proposed Agreed Orders and multiple adopted enforcement orders for industrial, energy and water sector facilities, with written comments on the proposed administrative orders due by 23 June 2026. For named operators, including major chemical and refinery sites, this consolidates penalties and corrective obligations and provides a short window to scrutinise orders, engage with TCEQ where appropriate, and recalibrate Texas environmental compliance and enforcement‑risk planning.
Illinois EPA Administrative Citation AC 2026-005 Against Hensley Township Proceeds With Petition for Review
Illinois regulators have recorded Administrative Citation AC 2026-005 against Hensley Township for an alleged land-based open dumping violation, with the case now progressing after the respondent filed a petition for review in late May 2026. This illustrates active enforcement of Illinois waste and land management rules, signalling that municipalities and waste operators should reassess local dumping controls, inspection findings, and documentation to avoid similar actions.
Maryland MDE Awards $17 Million Clean Water Funding and Secures $4.1 Million Construction Runoff Settlement
In May 2026 Maryland’s Department of the Environment and Attorney General approved nearly $17 million in Clean Water Commerce funding and a $4.1 million settlement to tackle nutrient and sediment pollution in key Chesapeake Bay watersheds. These actions reinforce Maryland’s pay‑for‑success restoration model and strict runoff enforcement, signalling higher expectations on developers and local partners while unlocking significant remediation investment for affected communities.
US FDA Class I Recall Of React Health VOCSN V+Pro Ventilators
In May 2026, the US FDA announced a Class I recall of React Health’s VOCSN V+Pro ventilators because a manufacturing defect can cause undetected oxygen leaks, reducing delivered oxygen and increasing fire risk. This forces hospitals and device managers to remove affected units from service immediately, substitute non-affected ventilators, and tighten recall and equipment risk controls for life-support devices.
Chemours and DuPont File New Brief Urging North Carolina Supreme Court to Dismiss AG Jackson’s PFAS Lawsuit
DuPont and Chemours have filed a new brief at the North Carolina Supreme Court seeking to dismiss Attorney General Jeff Jackson’s PFAS contamination lawsuit ahead of oral arguments set for 15 September 2026. The case could redefine the balance between environmental regulators and the attorney general, with major implications for PFAS liability exposure, settlement finality, and future mass-contamination litigation in North Carolina.
Environment Agency: Farm Pays Out £19,468 for Repeat Slurry Pollution Offences
The Environment Agency has secured a £19,468 payment against a Devon farm business after repeat slurry pollution incidents breached England’s Farming Rules for Water and environmental permitting laws. The case underscores active enforcement of existing water protection requirements for agricultural operators in England, highlighting compliance risks around slurry spreading and manure storage practices.
US FDA Class I Recall of Omnicell i.v.STATION Sterile Syringe Label Stock
In May 2026, the US FDA classified as a Class I recall Omnicell’s sterile syringe label stock used with its i.v.STATION automated compounding systems after identifying a risk of unlabeled or mislabeled IV syringes. Hospitals and compounding pharmacies using these systems must urgently remove and return the affected label lots, switch to alternative labels, and reinforce pharmacist verification to prevent serious medication errors.
Washington Ecology Issues Q4 2025 Environmental Penalties Totalling $3.84 Million
Washington’s Department of Ecology has published its Q4 2025 enforcement summary, detailing $3.84 million in environmental penalties for permit, reporting, spill prevention and water-use violations across multiple counties. The size of the Olympic Pipeline penalty and the breadth of smaller cases signal heightened scrutiny of fuel spills, stormwater controls and compliance documentation for facilities operating in Washington.
Brazilian Chamber of Deputies Approves Bill (PL 2564/2025) Limiting Environmental Precautionary Measures
Brazil’s Chamber of Deputies has approved Bill PL 2564/2025, which restricts environmental agencies’ use of precautionary embargoes, equipment destruction and remote-sensing evidence, and has sent the proposal to the Federal Senate. If enacted, this could slow rapid intervention against deforestation and other environmental crimes, weakening inspectors’ enforcement tools and increasing legal and reputational risks around environmental compliance in Brazil.
Australia TGA Issues Infringement Notices to Switch Nutrition Over Alleged Unlawful Advertising of Therapeutic Goods
Australia’s Therapeutic Goods Administration has issued four infringement notices totalling $79,200 to Switch Nutrition for allegedly using prohibited disease-related claims to advertise NMN and Vitamin D3 therapeutic products. This signals heightened enforcement of advertising and off-label promotion rules for therapeutic goods in Australia, increasing compliance risk for brands using aggressive health claims in consumer-facing marketing.
Australia Federal Court Imposes AU$2 Million Penalties on Key Promotional Products for Unlawful Import and Supply of COVID-19 Rapid Antigen Tests
Australia’s Federal Court has imposed AU$2 million in civil penalties on Key Promotional Products and an individual for importing, supplying and falsely marketing unapproved COVID-19 rapid antigen test kits in breach of the Therapeutic Goods Act. The ruling signals that importers and retailers of medical devices face significant corporate and personal liability if products are not entered in the ARTG or are misrepresented as 'TGA approved', particularly during public health emergencies.
Australia TGA Updates List of Licensed Therapeutic Goods Manufacturers
In May 2026, Australia's Therapeutic Goods Administration updated its list of licensed domestic manufacturers, granting 14 manufacturing licences while suspending 2 and revoking 8. These licensing decisions may affect supply chains and market access for therapeutic goods that rely on Australian manufacturers, so companies should verify whether critical contract manufacturing sites have gained or lost TGA licences and adjust quality and sourcing plans accordingly.
Australia TGA Enforces Against Magnesium Exercise-Performance Listed Medicines After Compliance Review
In May 2026 Australia’s Therapeutic Goods Administration reported that most magnesium-based listed medicines promoted for exercise performance lacked adequate evidence, leading to multiple ARTG cancellations, claim removals, and infringement notices. This reflects a tougher enforcement stance on efficacy claims for complementary and sports-performance medicines, so sponsors and brand owners should urgently review supporting data and labelling for similar products sold in Australia.
US FDA Issues Warning Letter to CSL Behring Over HIZENTRA DTC TV Ad Misbranding
FDA has issued a CBER warning letter to CSL Behring over a HIZENTRA direct-to-consumer TV advertisement that overstates efficacy, downplays serious risks, and is deemed misbranding under the Federal Food, Drug, and Cosmetic Act. This raises enforcement risk for DTC biologic promotion, signalling that manufacturers must rebalance benefit–risk messaging and deploy corrective communications quickly when FDA flags misleading advertising.
US FDA Closes Out Warning Letter 716297 to CSL Behring on Promotional Labelling for Biologics
US FDA has issued a closeout letter confirming that CSL Behring has adequately remediated promotional labelling violations cited in a 2025 warning letter for its biologic products. This closes a specific enforcement action but reinforces FDA’s ongoing scrutiny of biologics advertising, signalling continued regulatory risk for similar marketing practices across the sector.
Netherlands Prepares Draft Withdrawal of Tata Steel Coke Gas Plant Permits
In May 2026 the Dutch government informed Parliament that the Noordzeekanaalgebied Environmental Service is preparing a draft decision to withdraw Tata Steel IJmuiden’s KGF1 and KGF2 coke gas plant permits due to persistent breaches of environmental standards, including emissions of very concerning substances, alongside disputes over steel slag classification and a legal challenge to the company’s tailored agreement. Taken together, these steps sharply increase enforcement and continuity risk for Tata Steel’s Dutch operations, foreshadowing potential controlled closure of the coke plants and signalling tougher Dutch expectations on hazardous substances, waste handling and permit compliance for heavy industry.
US DOJ Seeks Comment on Proposed Modification to Clean Water Act Consent Decree for Fort Smith, Arkansas
In May 2026, the US Department of Justice proposed modifying a 2015 Clean Water Act consent decree with the City of Fort Smith, Arkansas, extending its term into 2038 and revising sewer rehabilitation milestones and funding obligations. The extended timeline and new requirements signal sustained federal scrutiny of municipal wastewater compliance under the Clean Water Act and give local stakeholders a short window to comment before the settlement terms are finalised.
Thailand DIW Allocates THB 30 Million To Clear 3,200 Tonnes Of Hazardous Waste At Ek Uthai Site
In May 2026, Thailand’s Department of Industrial Works told a Senate committee it has allocated THB 30 million to remove roughly 3,200 tonnes of hazardous industrial waste remaining at the Ek Uthai site and will seek to recover remediation costs from the operator. This signals more assertive enforcement and cost-recovery expectations around illegal hazardous waste disposal in Thailand, increasing liability and remediation risk for operators with weak waste management controls.
These are just a few of the most recent Litigation and Enforcement alerts. Foresight tracks every jurisdiction, every day — and surfaces only what affects your portfolio, with full citations and evidence.
Start free trialTopic context
Definition
Regulatory and civil litigation risks, including class actions, liability claims, and government enforcement proceedings related to chemical safety, environmental impact, and product compliance.
Industry relevance
Litigation and Enforcement developments can change product scope, supplier expectations, market access, reporting duties, and risk ownership. Foresight tracks the signals early so teams can respond before obligations become urgent.
Foresight tracking
Foresight monitors official sources, extracts structured regulatory intelligence, and maps alerts to a customer's products, substances, markets, and priorities so teams see the relevant signal with source evidence for review.
Everything you need to know about Foresight's regulatory intelligence platform
Still have questions? Get in touch with our team
Subscribe to Foresight Weekly for expert-picked regulatory developments across chemicals, sustainability, product safety, ESG, and HSE.
Free forever. Unsubscribe anytime.
Read by professionals at